查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2128608

病毒清除市場規模、佔有率、成長及全球產業分析、區域洞察，2026年至2034年的預測

Viral Clearance Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 128 Pages | 商品交期: 2-3個工作天內

價格

病毒清除市場的成長要素

全球病毒清除市場2025年達到8.341億美元，從2026年的9.7165億美元成長到2034年的38.0475億美元，預測期內（2026-2034年）CAGR為18.60%。北美地區憑藉其先進的生物製藥產業、強大的生物技術研發生態系統以及不斷成長的生物製藥生產計畫數量，在2025年佔據最大的市場佔有率，達到37.50%。

病毒清除檢測在確保生物製藥安全方面發揮著非常重要的作用，它能夠在生產過程中檢測、去除和去活化病毒污染物。這些檢測對於疫苗、重組蛋白、單株抗體、血液製品以及細胞和基因療法等生物來源製品非常重要。生物製藥研發的快速發展、疫苗產量的增加以及日益嚴格的監管要求，顯著提升了整個製藥和生物技術產業對病毒清除服務的需求。此外，越來越多的業務外包給專業的合約研究組織（CRO）也加速了市場成長。

2020年，由於封鎖和供應鏈中斷，新冠肺炎疫情對製造業活動產生了暫時性影響。然而，從2021年開始，隨著疫苗研發加速、生物製藥產量增加以及全球臨床研究活動的恢復，市場強勁復甦。

最新市場趨勢

病毒清除市場的關鍵趨勢之一是主要服務供應商不斷擴大病毒安全檢測設施。在生物製藥、生物相似藥和先進療法需求不斷成長的推動下，各公司重要的製藥基地建立新的實驗室，並擴大其檢測能力。

多家公司正大力投資建造專業的生物安全實驗室，以支持製藥企業從臨床前開發到商業化的整個流程。這些設施的擴建將有助於企業縮短交付週期、提高合規性並增強偵測能力。預計在預測期內，北美、歐洲和亞太地區對生物安全基礎設施的投資增加仍將是關鍵趨勢。

市場促進因素

製藥和生物技術公司研發投入的增加仍然是病毒去除市場最強勁的成長要素之一。癌症、心血管疾病、自體免疫疾病和糖尿病等慢性疾病發生率的上升顯著促進了生物製藥和生物相似藥的研發。由於所有生物製藥在上市前都需要進行全面的病毒安全性評估，因此對病毒去除檢測的需求持續穩定成長。

另一個重要的成長要素是生物製藥生產領域嚴格的國際監管標準的引進。監管機構現在要求在批准生物製藥、疫苗、血漿衍生產品和基因療法之前，進行全面的病毒安全性檢驗。國際指南進一步提升了病毒去除檢測的重要性，並鼓勵製藥公司投資先進的病毒去除、檢測和去活化技術。

市場限制因素

儘管市場成長前景強勁，但由於先進的病毒去除技術和實驗室設備高成本，該市場仍面臨挑戰。由於精密的分析設備需要大量資金投入，病毒去除服務對於小規模的生技公司往往價格昂貴。

此外，經驗豐富的病毒學家和專業實驗室人員短缺也為服務提供者帶來了營運挑戰。在擴建檢測設施的同時維持一支高素質的科研團隊會導致營運成本增加，這可能會限制某些地區的市場成長。

市場區隔

按方法論分類，病毒去除方法預計將在2026年成為全球市場的主要驅動力，這主要得益於其高效去除病毒污染物以及生技藥品研發投入的不斷成長。此外，由於血漿衍生療法和基因療法產品的核准數量不斷增加，病毒去活化方法的應用也取得了顯著進展。病毒檢測技術在確保生技藥品生產全製程的全面病毒安全性方面的重要性日益凸顯。

依應用領域分類，疫苗領域預計在2026年仍將保持最大的市場佔有率，這主要得益於免疫接種計劃的擴展、疫苗產量的增加以及對預防性醫療保健解決方案日益成長的需求。血液和血液製品仍將佔據重要的應用領域，但隨著全球再生醫學的進步，細胞療法和基因療法產品預計將實現最快的成長。

依終端用戶分類，預計在整個預測期內，製藥和生技產業仍將保持領先地位。由於生物製藥開發平臺的擴展和監管要求的日益嚴格，對病毒清除檢測的需求持續成長。隨著製藥公司擴大將病毒安全性檢測外包以提高效率並降低營運成本，合約研究組織（CRO）也呈現強勁成長動能。

區域展望

到2025年，北美以 3.127億美元的市場規模引領全球病毒清除市場，並預計在2026年達到 3.6544億美元。該地區受益於成熟的製藥產業、不斷成長的生物製藥產量、大量的臨床試驗以及對生物技術研究的大量投資。

到2025年，歐洲市場規模達到 2.3161億美元，預計到2026年將達到 2.6497億美元。強大的生物技術基礎設施、不斷增加的研發投資以及病毒檢測設施的擴建，將繼續支持該地區的成長。

亞太地區市場規模在2025年達到 2.5631億美元，在2026年達到 3.0371億美元。生物製藥生產的快速成長、政府對醫學研究投入的增加、CRO 網路的擴張以及生物製藥產量的增加，推動中國、印度、日本和其他亞洲國家的需求。

在拉丁美洲、中東和非洲地區，由於醫療保健基礎設施的擴張、製藥業投資的增加以及生物製藥製造技術的更廣泛應用，預計將穩步成長。

主要公司

病毒去除市場的主要參與者包括Merck KGaA、Charles River Laboratories、WuXi Biologics、Texcell、Vironova、Kedrion、Clean Cells、ViruSure GmbH、Sartorius AG、Syngene International Limited、Microbiologics。這些公司正不斷擴大實驗室基礎設施，加強生物安全檢測能力，並投資先進的病毒去除技術，以滿足日益成長的全球需求。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機會

第4章 主要考察

  • 技術進步
  • 主要行業趨勢
  • 監理展望
  • 主要產業趨勢（合併、收購、合作等）
  • 新冠疫情對市場的影響

第5章 全球病毒清除市場分析、洞察與預測（2021-2034年）

  • 市場分析、洞察與預測：依方法
    • 病毒清除方法
      • 層析
      • 過濾
      • 沉澱
    • 病毒去活化方法
      • pH值調節
      • 溶劑和界面活性劑（S/D）
      • 巴氏殺菌
      • 乾熱
      • 其他
    • 病毒檢測方法
      • 次世代定序（NGS）
      • 聚合酵素鏈鎖反應（PCR）
      • 體內試驗
      • 體外試驗
      • 其他
  • 市場分析、洞察與預測：依應用領域分類
    • 血液和血液製品
    • 重組蛋白
    • 細胞和基因療法產品
    • 疫苗
    • 其他
  • 市場分析、洞察與預測：依最終用戶分類
    • 製藥和生物技術產業
    • 學術研究機構
    • CRO
    • 其他
  • 市場分析、洞察與預測：依地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美病毒清除市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章 歐洲病毒清除市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章 亞太地區病毒清除市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章 拉丁美洲病毒清除市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章 中東和非洲病毒清除市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市場佔有率分析（2025年）
  • 公司簡介
    • Merck KGaA
    • Wuxi Biologics
    • Charles River Laboratories
    • Texcell
    • Vironova
    • Kedrion
    • Clean Cells
    • ViruSure GmbH
    • Sartorius AG
    • Syngene International Limited
    • Microbiologics
Product Code: FBI105611

Growth Factors of viral clearance Market

The global viral clearance market was valued at USD 834.1 million in 2025 and is projected to grow from USD 971.65 million in 2026 to USD 3,804.75 million by 2034, registering a CAGR of 18.60% during the forecast period (2026-2034). North America accounted for the largest 37.50% market share in 2025, supported by its advanced biopharmaceutical industry, strong biotechnology research ecosystem, and increasing number of biologics manufacturing projects.

Viral clearance studies play a critical role in ensuring the safety of biologics by detecting, removing, and inactivating viral contaminants during the manufacturing process. These studies are mandatory for products derived from biological sources, including vaccines, recombinant proteins, monoclonal antibodies, blood products, and cell & gene therapies. The rapid expansion of biologics development, increasing vaccine production, and stringent regulatory requirements are significantly boosting demand for viral clearance services across the pharmaceutical and biotechnology industries. Furthermore, growing outsourcing activities to specialized contract research organizations (CROs) are accelerating market expansion.

The COVID-19 pandemic temporarily affected manufacturing activities in 2020 due to lockdowns and supply chain disruptions. However, the market recovered strongly from 2021 onward as vaccine development accelerated, biologics production increased, and clinical research activities resumed worldwide.

Latest Market Trends

One of the major trends shaping the viral clearance market is the continuous expansion of viral safety testing facilities by leading service providers. Growing demand for biologics, biosimilars, and advanced therapies has encouraged companies to establish new laboratories and increase testing capacity across major pharmaceutical hubs.

Several companies are investing heavily in specialized biosafety laboratories capable of supporting pharmaceutical manufacturers from pre-clinical development through commercialization. Facility expansion also allows companies to offer faster turnaround times, improved regulatory compliance, and enhanced testing capabilities. Increasing investments in biosafety infrastructure across North America, Europe, and Asia Pacific are expected to remain a key trend throughout the forecast period.

Market Drivers

The increasing research and development expenditure by pharmaceutical and biotechnology companies remains one of the strongest growth drivers for the viral clearance market. Rising incidences of chronic diseases, including cancer, cardiovascular disorders, autoimmune diseases, and diabetes, have significantly increased the development of biologics and biosimilars. Since every biological product requires comprehensive viral safety evaluation before commercialization, demand for viral clearance studies continues to grow steadily.

Another important growth factor is the implementation of strict global regulatory standards for biologics manufacturing. Regulatory authorities require extensive viral safety validation before granting approvals for biological drugs, vaccines, plasma-derived products, and gene therapies. International guidelines have strengthened the importance of viral clearance testing, encouraging pharmaceutical manufacturers to invest in advanced viral removal, viral detection, and viral inactivation technologies.

Market Restraints

Despite strong growth prospects, the market faces challenges due to the high cost associated with advanced viral clearance technologies and laboratory equipment. Sophisticated analytical instruments require substantial capital investment, making viral clearance services expensive for smaller biotechnology companies.

In addition, the shortage of experienced virology professionals and specialized laboratory personnel creates operational challenges for service providers. Maintaining highly qualified scientific teams while expanding testing facilities increases operational costs, which may restrict market growth in certain regions.

Market Segmentation

Based on method, the viral removal method segment is expected to dominate the global market in 2026 owing to its high efficiency in eliminating viral contaminants and increasing investments in biologics research. Viral inactivation methods are also witnessing significant adoption due to growing approvals of plasma-derived therapies and gene therapy products. Viral detection technologies continue to gain importance for ensuring comprehensive viral safety during biologics manufacturing.

By application, the vaccines segment is expected to maintain the largest market share in 2026 due to increasing immunization programs, rising vaccine production, and growing demand for preventive healthcare solutions. Blood and blood products continue to represent a significant application area, while cellular and gene therapy products are projected to register the fastest growth as regenerative medicine advances worldwide.

Based on end-user, the pharmaceutical and biotechnology industry is anticipated to remain the leading segment throughout the forecast period. Growing biologics development pipelines and stringent regulatory requirements continue to increase demand for viral clearance studies. Contract research organizations are also witnessing strong growth as pharmaceutical companies increasingly outsource viral safety testing to improve efficiency and reduce operational costs.

Regional Outlook

North America dominated the global viral clearance market with a valuation of USD 312.7 million in 2025 and is projected to reach USD 365.44 million in 2026. The region benefits from a mature pharmaceutical industry, increasing biologics production, numerous clinical trials, and substantial investments in biotechnology research.

Europe accounted for USD 231.61 million in 2025 and is expected to reach USD 264.97 million in 2026. Strong biotechnology infrastructure, increasing R&D investments, and expansion of viral testing laboratories continue to support regional growth.

Asia Pacific generated USD 256.31 million in 2025 and is forecast to reach USD 303.71 million in 2026. Rapid growth of biopharmaceutical manufacturing, rising government funding for healthcare research, expanding CRO networks, and increasing biologics production are driving demand across China, India, Japan, and other Asian countries.

Latin America and the Middle East & Africa are expected to witness steady growth due to expanding healthcare infrastructure, increasing pharmaceutical investments, and rising adoption of biologics manufacturing technologies.

Key Companies

Leading companies operating in the viral clearance market include Merck KGaA, Charles River Laboratories, WuXi Biologics, Texcell, Vironova, Kedrion, Clean Cells, ViruSure GmbH, Sartorius AG, Syngene International Limited, and Microbiologics. These companies continue expanding laboratory infrastructure, strengthening biosafety testing capabilities, and investing in advanced viral clearance technologies to meet growing global demand.

Conclusion

The viral clearance market is expected to experience substantial growth between 2026 and 2034, supported by rising biologics production, expanding vaccine development, increasing regulatory emphasis on viral safety, and growing investments in pharmaceutical research. Continuous technological advancements, expansion of biosafety laboratories, and increasing outsourcing of viral clearance studies will further strengthen market opportunities, making viral clearance an indispensable component of modern biopharmaceutical manufacturing.

Segmentation By Method

  • Viral Removal Method
    • Chromatography
    • Filtration
    • Precipitation
  • Viral Inactivation Method
    • pH Modification
    • Solvent Detergent (S/D)
    • Pasteurization
    • Dry Heat
    • Others
  • Viral Detection Method
    • Next Generation Sequencing (NGS)
    • Polymerase Chain Reaction (PCR)
    • In vivo Assay
    • In vitro Assay
    • Others

By Application

  • Blood and Blood Products
  • Recombinant Proteins
  • Cellular & Gene Therapy Products
  • Vaccines
  • Others

By End-user

  • Pharmaceutical and Biotech Industry
  • Academic Research Institutes
  • CROs
  • Others

By Geography

  • North America (By Method, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Method, Application, End-user, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Method, Application, End-user, and Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Method, Application, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Method, Application, End-user, and Country/Sub-region)
    • South Africa
    • GCC
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Technological Advancements
  • 4.2. Key Industry Trends
  • 4.3. Regulatory Scenario
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.5. Impact of COVID-19 on the Market

5. Global Viral Clearance Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Method
    • 5.1.1. Viral Removal Method
      • 5.1.1.1. Chromatography
      • 5.1.1.2. Filtration
      • 5.1.1.3. Precipitation
    • 5.1.2. Viral Inactivation Method
      • 5.1.2.1. pH Modification
      • 5.1.2.2. Solvent Detergent (S/D)
      • 5.1.2.3. Pasteurization
      • 5.1.2.4. Dry Heat
      • 5.1.2.5. Others
    • 5.1.3. Viral Detection Method
      • 5.1.3.1. Next Generation Sequencing (NGS)
      • 5.1.3.2. Polymerase Chain Reaction (PCR)
      • 5.1.3.3. In vivo Assay
      • 5.1.3.4. In vitro Assay
      • 5.1.3.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Applications
    • 5.2.1. Blood and Blood Products
    • 5.2.2. Recombinant Proteins
    • 5.2.3. Cellular & Gene Therapy Products
    • 5.2.4. Vaccines
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Pharmaceutical and Biotech Industry
    • 5.3.2. Academic Research Institutes
    • 5.3.3. CROs
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Geography
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Viral Clearance Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Method
    • 6.1.1. Viral Removal Method
      • 6.1.1.1. Chromatography
      • 6.1.1.2. Filtration
      • 6.1.1.3. Precipitation
    • 6.1.2. Viral Inactivation Method
      • 6.1.2.1. pH Modification
      • 6.1.2.2. Solvent Detergent (S/D)
      • 6.1.2.3. Pasteurization
      • 6.1.2.4. Dry Heat
      • 6.1.2.5. Others
    • 6.1.3. Viral Detection Method
      • 6.1.3.1. Next Generation Sequencing (NGS)
      • 6.1.3.2. Polymerase Chain Reaction (PCR)
      • 6.1.3.3. In vivo Assay
      • 6.1.3.4. In vitro Assay
      • 6.1.3.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Applications
    • 6.2.1. Blood and Blood Products
    • 6.2.2. Recombinant Proteins
    • 6.2.3. Cellular & Gene Therapy Products
    • 6.2.4. Vaccines
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Pharmaceutical and Biotech Industry
    • 6.3.2. Academic Research Institutes
    • 6.3.3. CROs
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Viral Clearance Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Method
    • 7.1.1. Viral Removal Method
      • 7.1.1.1. Chromatography
      • 7.1.1.2. Filtration
      • 7.1.1.3. Precipitation
    • 7.1.2. Viral Inactivation Method
      • 7.1.2.1. pH Modification
      • 7.1.2.2. Solvent Detergent (S/D)
      • 7.1.2.3. Pasteurization
      • 7.1.2.4. Dry Heat
      • 7.1.2.5. Others
    • 7.1.3. Viral Detection Method
      • 7.1.3.1. Next Generation Sequencing (NGS)
      • 7.1.3.2. Polymerase Chain Reaction (PCR)
      • 7.1.3.3. In vivo Assay
      • 7.1.3.4. In vitro Assay
      • 7.1.3.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Applications
    • 7.2.1. Blood and Blood Products
    • 7.2.2. Recombinant Proteins
    • 7.2.3. Cellular & Gene Therapy Products
    • 7.2.4. Vaccines
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Pharmaceutical and Biotech Industry
    • 7.3.2. Academic Research Institutes
    • 7.3.3. CROs
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Viral Clearance Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Method
    • 8.1.1. Viral Removal Method
      • 8.1.1.1. Chromatography
      • 8.1.1.2. Filtration
      • 8.1.1.3. Precipitation
    • 8.1.2. Viral Inactivation Method
      • 8.1.2.1. pH Modification
      • 8.1.2.2. Solvent Detergent (S/D)
      • 8.1.2.3. Pasteurization
      • 8.1.2.4. Dry Heat
      • 8.1.2.5. Others
    • 8.1.3. Viral Detection Method
      • 8.1.3.1. Next Generation Sequencing (NGS)
      • 8.1.3.2. Polymerase Chain Reaction (PCR)
      • 8.1.3.3. In vivo Assay
      • 8.1.3.4. In vitro Assay
      • 8.1.3.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Applications
    • 8.2.1. Blood and Blood Products
    • 8.2.2. Recombinant Proteins
    • 8.2.3. Cellular & Gene Therapy Products
    • 8.2.4. Vaccines
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Pharmaceutical and Biotech Industry
    • 8.3.2. Academic Research Institutes
    • 8.3.3. CROs
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Viral Clearance Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Method
    • 9.1.1. Viral Removal Method
      • 9.1.1.1. Chromatography
      • 9.1.1.2. Filtration
      • 9.1.1.3. Precipitation
    • 9.1.2. Viral Inactivation Method
      • 9.1.2.1. pH Modification
      • 9.1.2.2. Solvent Detergent (S/D)
      • 9.1.2.3. Pasteurization
      • 9.1.2.4. Dry Heat
      • 9.1.2.5. Others
    • 9.1.3. Viral Detection Method
      • 9.1.3.1. Next Generation Sequencing (NGS)
      • 9.1.3.2. Polymerase Chain Reaction (PCR)
      • 9.1.3.3. In vivo Assay
      • 9.1.3.4. In vitro Assay
      • 9.1.3.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Applications
    • 9.2.1. Blood and Blood Products
    • 9.2.2. Recombinant Proteins
    • 9.2.3. Cellular & Gene Therapy Products
    • 9.2.4. Vaccines
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Pharmaceutical and Biotech Industry
    • 9.3.2. Academic Research Institutes
    • 9.3.3. CROs
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Viral Clearance Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Method
    • 10.1.1. Viral Removal Method
      • 10.1.1.1. Chromatography
      • 10.1.1.2. Filtration
      • 10.1.1.3. Precipitation
    • 10.1.2. Viral Inactivation Method
      • 10.1.2.1. pH Modification
      • 10.1.2.2. Solvent Detergent (S/D)
      • 10.1.2.3. Pasteurization
      • 10.1.2.4. Dry Heat
      • 10.1.2.5. Others
    • 10.1.3. Viral Detection Method
      • 10.1.3.1. Next Generation Sequencing (NGS)
      • 10.1.3.2. Polymerase Chain Reaction (PCR)
      • 10.1.3.3. In vivo Assay
      • 10.1.3.4. In vitro Assay
      • 10.1.3.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Applications
    • 10.2.1. Blood and Blood Products
    • 10.2.2. Recombinant Proteins
    • 10.2.3. Cellular & Gene Therapy Products
    • 10.2.4. Vaccines
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Pharmaceutical and Biotech Industry
    • 10.3.2. Academic Research Institutes
    • 10.3.3. CROs
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Merck KGaA
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Wuxi Biologics
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Charles River Laboratories
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Texcell
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Vironova
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Kedrion
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Clean Cells
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. ViruSure GmbH
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Sartorius AG
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Syngene International Limited
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. Microbiologics
      • 11.2.11.1. Overview
      • 11.2.11.2. Products & Services
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Viral Clearance Market Revenue (USD million) Forecast, by Method, 2021-2034
  • Table 2: Global Viral Clearance Market Revenue (USD million) Forecast, by Viral Removal Method, 2021-2034
  • Table 3: Global Viral Clearance Market Revenue (USD million) Forecast, by Viral Inactivation Method, 2021-2034
  • Table 4: Global Viral Clearance Market Revenue (USD million) Forecast, by Viral Detection Method, 2021-2034
  • Table 5: Global Viral Clearance Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 6: Global Viral Clearance Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 7: Global Viral Clearance Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 8: North America Viral Clearance Market Revenue (USD million) Forecast, by Method, 2021-2034
  • Table 9: North America Viral Clearance Market Revenue (USD million) Forecast, by Viral Removal Method, 2021-2034
  • Table 10: North America Viral Clearance Market Revenue (USD million) Forecast, by Viral Inactivation Method, 2021-2034
  • Table 11: North America Viral Clearance Market Revenue (USD million) Forecast, by Viral Detection Method, 2021-2034
  • Table 12: North America Viral Clearance Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 13: North America Viral Clearance Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 14: North America Viral Clearance Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 15: Europe Viral Clearance Market Revenue (USD million) Forecast, by Method, 2021-2034
  • Table 16: Europe Viral Clearance Market Revenue (USD million) Forecast, by Viral Removal Method, 2021-2034
  • Table 17: Europe Viral Clearance Market Revenue (USD million) Forecast, by Viral Inactivation Method, 2021-2034
  • Table 18: Europe Viral Clearance Market Revenue (USD million) Forecast, by Viral Detection Method, 2021-2034
  • Table 19: Europe Viral Clearance Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 20: Europe Viral Clearance Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 21: Europe Viral Clearance Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, by Method, 2021-2034
  • Table 23: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, by Viral Removal Method, 2021-2034
  • Table 24: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, by Viral Inactivation Method, 2021-2034
  • Table 25: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, by Viral Detection Method, 2021-2034
  • Table 26: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 27: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 28: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Viral Clearance Market Revenue (USD million) Forecast, by Method, 2021-2034
  • Table 30: Latin America Viral Clearance Market Revenue (USD million) Forecast, by Viral Removal Method, 2021-2034
  • Table 31: Latin America Viral Clearance Market Revenue (USD million) Forecast, by Viral Inactivation Method, 2021-2034
  • Table 32: Latin America Viral Clearance Market Revenue (USD million) Forecast, by Viral Detection Method, 2021-2034
  • Table 33: Latin America Viral Clearance Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 34: Latin America Viral Clearance Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 35: Latin America Viral Clearance Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, by Method, 2021-2034
  • Table 37: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, by Viral Removal Method, 2021-2034
  • Table 38: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, by Viral Inactivation Method, 2021-2034
  • Table 39: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, by Viral Detection Method, 2021-2034
  • Table 40: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 41: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 42: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Viral Clearance Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 01: Global Viral Clearance Market Value Share (%), By Method, 2025 & 2034
  • Figure 02: Global Viral Clearance Market Value Share (%), By Application, 2025 & 2034
  • Figure 03: Global Viral Clearance Market Value Share (%), By End-user, 2025 & 2034
  • Figure 04: Global Viral Clearance Market Value Share (%), By Region, 2025 & 2034
  • Figure 05: North America Viral Clearance Market Value (USD million), By Method, 2025 & 2034
  • Figure 06: North America Viral Clearance Market Value Share (%), By Method, 2025
  • Figure 07: North America Viral Clearance Market Value (USD million), By Application, 2025 & 2034
  • Figure 08: North America Viral Clearance Market Value Share (%), By Application, 2025
  • Figure 09: North America Viral Clearance Market Value (USD million), By End-user, 2025 & 2034
  • Figure 10: North America Viral Clearance Market Value Share (%), By End-user, 2025
  • Figure 11: North America Viral Clearance Market Value (USD million), By Region, 2025 & 2034
  • Figure 12: North America Viral Clearance Market Value Share (%), By Region, 2025
  • Figure 13: Europe Viral Clearance Market Value (USD million), By Method, 2025 & 2034
  • Figure 14: Europe Viral Clearance Market Value Share (%), By Method, 2025
  • Figure 15: Europe Viral Clearance Market Value (USD million), By Application, 2025 & 2034
  • Figure 16: Europe Viral Clearance Market Value Share (%), By Application, 2025
  • Figure 17: Europe Viral Clearance Market Value (USD million), By End-user, 2025 & 2034
  • Figure 18: Europe Viral Clearance Market Value Share (%), By End-user, 2025
  • Figure 19: Europe Viral Clearance Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 20: Europe Viral Clearance Market Value Share (%), By Country/Sub-region, 2025
  • Figure 21: Asia Pacific Viral Clearance Market Value (USD million), By Method, 2025 & 2034
  • Figure 22: Asia Pacific Viral Clearance Market Value Share (%), By Method, 2025
  • Figure 23: Asia Pacific Viral Clearance Market Value (USD million), By Application, 2025 & 2034
  • Figure 24: Asia Pacific Viral Clearance Market Value Share (%), By Application, 2025
  • Figure 25: Asia Pacific Viral Clearance Market Value (USD million), By End-user, 2025 & 2034
  • Figure 26: Asia Pacific Viral Clearance Market Value Share (%), By End-user, 2025
  • Figure 27: Asia Pacific Viral Clearance Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 28: Asia Pacific Viral Clearance Market Value Share (%), By Country/Sub-region, 2025
  • Figure 29: Latin America Viral Clearance Market Value (USD million), By Method, 2025 & 2034
  • Figure 30: Latin America Viral Clearance Market Value Share (%), By Method, 2025
  • Figure 31: Latin America Viral Clearance Market Value (USD million), By Application, 2025 & 2034
  • Figure 32: Latin America Viral Clearance Market Value Share (%), By Application, 2025
  • Figure 33: Latin America Viral Clearance Market Value (USD million), By End-user, 2025 & 2034
  • Figure 34: Latin America Viral Clearance Market Value Share (%), By End-user, 2025
  • Figure 35: Latin America Viral Clearance Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 36: Latin America Viral Clearance Market Value Share (%), By Country/Sub-region, 2025
  • Figure 37: Middle East & Africa Viral Clearance Market Value (USD million), By Method, 2025 & 2034
  • Figure 38: Middle East & Africa Viral Clearance Market Value Share (%), By Method, 2025
  • Figure 39: Middle East & Africa Viral Clearance Market Value (USD million), By Application, 2025 & 2034
  • Figure 40: Middle East & Africa Viral Clearance Market Value Share (%), By Application, 2025
  • Figure 41: Middle East & Africa Viral Clearance Market Value (USD million), By End-user, 2025 & 2034
  • Figure 42: Middle East & Africa Viral Clearance Market Value Share (%), By End-user, 2025
  • Figure 43: Middle East & Africa Viral Clearance Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 44: Middle East & Africa Viral Clearance Market Value Share (%), By Country/Sub-region, 2025
  • Figure 45: Global Viral Clearance Market Share (%), By Company, 2025